Review Article

Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment

Table 1

TPP-linked MTAs.

Mitochondria-targeted antioxidantsBioactive componentLinkerEffectsReference

MitoEVitamin E2-Carbon aliphatic linker(1) Minimized lipid peroxidation and protected cells from oxidative damage
(2) Eliminated H2O2-induced oxidative stress and caspase activation in cells
(3) Accumulated in tissues (heart, brain, muscle, liver, and kidney) and protected tissues from oxidative damage
[28, 30]
Mito-vitamin E derivationVitamin E11-Alkyl linker(1) Inhibited energy metabolism and promote cell death
(2) Antitumor properties
[31, 32]
SkQ1
SkQR1
Plastoquinone10-Alkyl linker(1) Minimized lipid peroxidation and ROS-induced apoptosis
(2) Beneficial roles in many diseases including aging, stroke, myocardial infarction, sarcopenia, dry eye syndrome, vascular inflammation
[33, 34]
MitoQCoenzyme Q10-Alkyl linker(1) Penetrated the mitochondrial membrane and inhibited lipid peroxidation
(2) Beneficial roles in animal models of alcoholic fatty liver, neurodegenerative diseases, ischemia-reperfusion, hypertension, sepsis, and kidney damage in type I diabetes
[35, 36]
MitoC MitoVitC11Vitamin CThioalkyl linker(1) Prevented mitochondrial lipid peroxidation and protected mitochondrial aconitase
(2) Scavenged O2–, peroxyl radicals, and Fe3+ and could be rapidly recycled to the active ascorbate moiety
[37]
MitoSODM40403Thioalkyl linker(1) Regulated the mitochondrial redox system to convert ROS
(2) Reversed the rapid and progressive inhibition of aconitase through redox cycling
(3) Retained Mn2+ under nonacidic conditions
[38, 39]

Notes: ΔΨm: mitochondrial membrane potential; M40403: a macrocyclic Mn SOD mimetic system; ROS: reactive oxygen species; TPP: triphenylphosphonium.